1. Designing clinical practice feedback reports: three steps illustrated in Veterans Health Affairs long-term care facilities and programs, Implementation Science (IS), Landis-Lewis Z, Kononowech J, Scott WJ, Hogikyan RV, Carpenter JG, Periyakoil VS, Miller SC, Levy C, Ersek M, Sales A.
  2. Capture of micrococcin biosynthetic intermediates reveals C-terminal processing as an obligatory step for in vivo maturation, Proc Natl Acad Sci USA, Kathryn D Bewley, Philip R Bennallack, Mark A Burlingame, Richard A Robison, Joel S Griffitts, Susan M Miller.
  3. Reconstitution and Minimization of a Micrococcin Biosynthetic Pathway in Bacillus subtilis, Journal of Bacteriology, Bennallack PR, Bewley KD, Burlingame MA, Robison RA, Miller SM, Griffitts JS.
  4. Establishing disease causality for a novel gene variant in familial dilated cardiomyopathy using a functional in-vitro assay of regulated thin filaments and human cardiac myosin, BMC Medical Genetics, Pan S, Sommese RF, Sallam KI, Nag S, Sutton S, Miller SM, Spudich JA, Ruppel KM, Ashley EA.
  5. Organic and inorganic mercurials have distinct effects on cellular thiols, metal homeostasis, and Fe-binding proteins in Escherichia coli, Journal of Biological Inorganic Chemistry (JBIC): a publication of the Society of Biological Inorganic Chemistry, LaVoie SP, Mapolelo DT, Cowart DM, Polacco BJ, Johnson MK, Scott RA, Miller SM, Summers AO.
  6. X-ray structure of a Hg2+ complex of mercuric reductase (MerA) and quantum mechanical/molecular mechanical study of Hg2+ transfer between the C-terminal and buried catalytic site cysteine pairs, Biochemistry, Lian P, Guo HB, Riccardi D, Dong A, Parks JM, Xu Q, Pai EF, Miller SM, Wei DQ, Smith JC, Guo H.
  7. Structure and dynamics of a compact state of a multidomain protein, the mercuric ion reductase, Biophysical Journal, Hong L, Sharp MA, Poblete S, Biehl R, Zamponi M, Szekely N, Appavou MS, Winkler RG, Nauss RE, Johs A, Parks JM, Yi Z, Cheng X, Liang L, Ohl M, Miller SM, Richter D, Gompper G, Smith JC.
  8. Effects of Troponin T Cardiomyopathy Mutations on the Calcium Sensitivity of the Regulated Thin Filament and the Actomyosin Cross-bridge Kinetics of Human ß-Cardiac Myosin, PLOS One, Sommese RF, Nag S, Sutton S, Miller SM, Spudich JA, Ruppel KM.
  9. Why Mercury Prefers Soft Ligands, J. Phys. Chem. Lett., Riccardi D, Guo H-B, Parks JM, Gu B, Summers AO, Miller SM, Liang L, Smith JC..
  10. Structural characterization of intramolecular Hg(2+) transfer between flexibly linked domains of mercuric ion reductase, Journal of Molecular Biology, Johs A, Harwood IM, Parks JM, Nauss RE, Smith JC, Liang L, Miller SM.
  11. Discovering mercury protein modifications in whole proteomes using natural isotope distributions observed in liquid chromatography-tandem mass spectrometry, Molecular & Cellular Proteomics (MCP), Polacco BJ, Purvine SO, Zink EM, Lavoie SP, Lipton MS, Summers AO, Miller SM.
  12. Evaluation of the pKa Values and Ionization Sequence of Bumetanide in Water Using 1H and 13C NMR and UV Spectroscopy, Drug Development Research, Song B, Galande AK, Kodokula K, Moos WH, Miller SM.
  13. NmerA of Tn501 mercuric ion reductase: structural modulation of the pKa values of the metal binding cysteine thiols, Biochemistry, Ledwidge R, Hong B, Dötsch V, Miller SM.
  14. Direct measurement of mercury(II) removal from organomercurial lyase (MerB) by tryptophan fluorescence: NmerA domain of coevolved ?-proteobacterial mercuric ion reductase (MerA) is more efficient than MerA catalytic core or glutathione, Biochemistry, Hong B, Nauss R, Harwood IM, Miller SM.
  15. Structure and conformational dynamics of the metalloregulator MerR upon binding of Hg(II), Journal of Molecular Biology, Guo HB, Johs A, Parks JM, Olliff L, Miller SM, Summers AO, Liang L, Smith JC.
  16. Mechanism of Hg-C protonolysis in the organomercurial lyase MerB, Journal of the American Chemical Society, Parks JM, Guo H, Momany C, Liang L, Miller SM, Summers AO, Smith JC.
  17. Kinetic buffering of cross talk between bacterial two-component sensors, Journal of Molecular Biology, Groban ES, Clarke EJ, Salis HM, Miller SM, Voigt CA.
  18. The mechanism of inhibition of antibody-based inhibitors of membrane-type serine protease 1 (MT-SP1), Journal of Molecular Biology, Farady CJ, Sun J, Darragh MR, Miller SM, Craik CS.
  19. NmerA, the metal binding domain of mercuric ion reductase, removes Hg2+ from proteins, delivers it to the catalytic core, and protects cells under glutathione-depleted conditions, Biochemistry, Ledwidge R, Patel B, Dong A, Fiedler D, Falkowski M, Zelikova J, Summers AO, Pai EF, Miller SM.
  20. Direct monitoring of metal ion transfer between two trafficking proteins, Journal of the American Chemical Society, Ledwidge R, Soinski R, Miller SM.
  21. Mercury adaptation among bacteria from a deep-sea hydrothermal vent, Applied and Environmental Microbiology, Vetriani C, Chew YS, Miller SM, Yagi J, Coombs J, Lutz RA, Barkay T.
  22. Quantitative identification of the protonation state of histidines in vitro and in vivo, Biochemistry, Shimba N, Serber Z, Ledwidge R, Miller SM, Craik CS, Dötsch V.
  23. Bacterial mercury resistance from atoms to ecosystems, FEMS Microbiology Reviews, Barkay T, Miller SM, Summers AO.
  24. Evaluation of parameters critical to observing proteins inside living Escherichia coli by in-cell NMR spectroscopy, Journal of the American Chemical Society, Serber Z, Ledwidge R, Miller SM, Dötsch V.
  25. High-resolution macromolecular NMR spectroscopy inside living cells, Journal of the American Chemical Society, Serber Z, Keatinge-Clay AT, Ledwidge R, Kelly AE, Miller SM, Dötsch V.
  26. Stabilization of a novel enzyme.substrate intermediate in the Y206F mutant of Candida albicans EBP1: evidence for acid catalysis, Biochemistry, Buckman J, Miller SM.
  27. Transient kinetics and intermediates formed during the electron transfer reaction catalyzed by Candida albicans estrogen binding protein, Biochemistry, Buckman J, Miller SM.
  28. No metal cofactor in orotidine 5'-monophosphate decarboxylase, Biochemical and Biophysical Research Communications, Cui W, DeWitt JG, Miller SM, Wu W.
  29. Investigation of the kinetic mechanism of cytidine 5'-monophosphate N-acetylneuraminic acid synthetase from Haemophilus ducreyi with new insights on rate-limiting steps from product inhibition analysis, Biochemistry, Samuels NM, Gibson BW, Miller SM.
  30. Alternative routes for entry of HgX2 into the active site of mercuric ion reductase depend on the nature of the X ligands, Biochemistry, Engst S, Miller SM.
  31. Bacterial detoxification of Hg(II) and organomercurials, Essays in Biochemistry, Miller SM.
  32. Binding and reactivity of Candida albicans estrogen binding protein with steroid and other substrates, Biochemistry, Buckman J, Miller SM.
  33. Rapid reduction of Hg(II) by mercuric ion reductase does not require the conserved C-terminal cysteine pair using HgBr2 as the substrate, Biochemistry, Engst S, Miller SM.
  34. Decarboxylation of 1,3- Dimethylorotic Acid Revisited: Determining the Role of N-1, Bioorg & Med Chem Lett, Wu W, Ley-han A, Wong FM, Austin TJ, Miller SM.
  35. 2'-fluoro-2'-deoxy-D-arabinoflavin: characterization of a novel flavin and its effects on the formation and stability of two-electron-reduced mercuric ion reductase, Biochemistry, Miller SM.
  36. Comparison of the proteolytic susceptibilities of homologous L‐amino acid, D‐amino acid, and N‐substituted glycine peptide and peptoid oligomers, Drug Dev Res, Miller SM, Simon RJ, Ng S, Zuckermann, RN, Kerr JM, Moos WH.
  37. Mechanism of p-hydroxyphenylacetate-3-hydroxylase. A two-protein enzyme, The Journal of Biological Chemistry, Arunachalam U, Massey V, Miller SM.
  38. Proteolytic studies of homologous peptide and N-substituted glycine peptoid oligomers, Bioorg & Med Chem Letters, Miller SM, Simon RJ, Ng S, Zuckermann RN, Kerr JM, Moos WH.
  39. C-terminal cysteines of Tn501 mercuric ion reductase, Biochemistry, Moore MJ, Miller SM, Walsh CT.
  40. Communication between the active sites in dimeric mercuric ion reductase: an alternating sites hypothesis for catalysis, Biochemistry, Miller SM, Massey V, Williams CH, Ballou DP, Walsh CT.
  41. Use of a site-directed triple mutant to trap intermediates: demonstration that the flavin C(4a)-thiol adduct and reduced flavin are kinetically competent intermediates in mercuric ion reductase, Biochemistry, Miller SM, Massey V, Ballou D, Williams CH, Distefano MD, Moore MJ, Walsh CT.
  42. Evidence for the participation of Cys558 and Cys559 at the active site of mercuric reductase, Biochemistry, Miller SM, Moore MJ, Massey V, Williams CH, Distefano MD, Ballou DP, Walsh CT.
  43. Two-electron reduced mercuric reductase binds Hg(II) to the active site dithiol but does not catalyze Hg(II) reduction, The Journal of Biological Chemistry, Miller SM, Ballou DP, Massey V, Williams CH, Walsh CT.
  44. Secondary isotope effects and structure-reactivity correlations in the dopamine beta-monooxygenase reaction: evidence for a chemical mechanism, Biochemistry, Miller SM, Klinman JP.
  45. Magnitude of intrinsic isotope effects in the dopamine beta-monooxygenase reaction, Biochemistry, Miller SM, Klinman JP.
  46. Deduction of kinetic mechanisms from primary hydrogen isotope effects: dopamine beta-monooxygenase--a case history, Methods in Enzymology, Miller SM, Klinman JP.